Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2026, Vol. 40 ›› Issue (4): 1-9.doi: 10.6040/j.issn.1673-3770.0.2025.223
• Original Article • Next Articles
HOU Zhenxing1, LUO Jingjing2, WANG Nan2, LI Ao1,2, GAO Xia1
CLC Number:
| [1] Check W. How do things stand with cisplatin?[J]. JAMA, 1978, 240(23): 2521-2525 [2] Lee J, Fernandez K, Cunningham LL. Hear and now: ongoing clinical trials to prevent drug-induced hearing loss[J]. Annu Rev Pharmacol Toxicol, 2024, 64: 211-230. DOI:10.1146/annurev-pharmtox-033123-114106 [3] Dhillon S. Sodium thiosulfate: pediatric first approval[J]. Paediatr Drugs, 2023, 25(2): 239-244. DOI:10.1007/s40272-022-00550-x [4] Freyer DR, Chen L, Krailo MD, et al. Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer(ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial[J]. Lancet Oncol, 2017, 18(1): 63-74. DOI:10.1016/S1470-2045(16)30625-8 [5] Freyer DR, Brock PR, Chang KW, et al. Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline[J]. Lancet Child Adolesc Health, 2020, 4(2): 141-150. DOI:10.1016/S2352-4642(19)30336-0 [6] Lye J, Delaney DS, Leith FK, et al. Recent therapeutic progress and future perspectives for the treatment of hearing loss[J]. Biomedicines, 2023, 11(12): 3347. DOI:10.3390/biomedicines11123347 [7] Nan BY, Zhao ZR, Jiang KL, et al. Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo[J]. Acta Pharm Sin B, 2022, 12(1): 167-181. DOI:10.1016/j.apsb.2021.07.002 [8] Lin YH, Liang R, Xie KR, et al. Puerarin inhibits cisplatin-induced ototoxicity in mice through regulation of TRPV1-dependent calcium overload[J]. Biochem Pharmacol, 2024, 220: 115962. DOI:10.1016/j.bcp.2023.115962 [9] Hsieh CY, Lin JN, Kang TY, et al. Otoprotective effects of fucoidan reduce cisplatin-induced ototoxicity in mouse cochlear UB/OC-2 cells[J]. Int J Mol Sci, 2023, 24(4): 3561. DOI:10.3390/ijms24043561 [10] 高鑫, 尹柏坤, 左军. 黄芩提取物及其有效成分的药理作用研究进展[J]. 中医药学报, 2025, 53(3): 112-117. DOI:10.19664/j.cnki.1002-2392.250063 [11] 于文静, 杨苗, 贺春香, 等. 黄芩苷通过TLR4/MyD88/NF-κB通路抑制链脲佐菌素诱导的阿尔茨海默病大鼠模型神经炎症反应[J]. 中国药理学通报, 2023, 39(1): 83-89. DOI:10.12360/CPB202204021 [12] 张倩, 李惠香, 刘攀, 等. 黄芩素的体外抗炎及抗氧化活性研究[J]. 烟台大学学报(自然科学与工程版), 2018, 31(3): 232-238. DOI:10.13951/j.cnki.37-1213/n.2018.03.008 [13] Guo MY, Zhang NS, Li DP, et al. Baicalin plays an anti-inflammatory role through reducing nuclear factor-κB and p38 phosphorylation in S. aureus-induced mastitis[J]. IntImmunopharmacol, 2013, 16(2): 125-130. DOI:10.1016/j.intimp.2013.03.006 [14] Wang CZ, Li XL, Wang QF, et al. Selective fraction of Scutellaria baicalensis and its chemopreventive effects on MCF-7 human breast cancer cells[J]. Phytomedicine, 2010, 17(1): 63-68. DOI:10.1016/j.phymed.2009.07.003 [15] Chattaraj A, Syed MP, Low CA, et al. Cisplatin-induced ototoxicity: a concise review of the burden, prevention, and interception strategies[J]. JCO Oncol Pract, 2023, 19(5): 278-283. DOI:10.1200/OP.22.00710 [16] Wang XL, Zhou YY, Wang DL, et al. Cisplatin-induced ototoxicity: From signaling network to therapeutic targets[J]. Biomed Pharmacother, 2023, 157: 114045. DOI:10.1016/j.biopha.2022.114045 [17] 王岩, 韩锋产. 顺铂耳毒性的研究进展[J]. 中华耳科学杂志, 2023, 21(3): 401-404. DOI:10.3969/j.issn.1672-2922.2023.03.021 [18] Xiang L, Liu Y, Liu JL. Regarding the effect of cisplatin-based chemotherapy on hearing loss in children with cancer[J]. Am J Otolaryngol, 2024, 45(4): 104367. DOI:10.1016/j.amjoto.2024.104367 [19] Yu DH, Gu JY, Chen YM, et al. Current strategies to combat cisplatin-induced ototoxicity[J]. Front Pharmacol, 2020, 11: 999. DOI:10.3389/fphar.2020.00999 [20] Tang Q, Wang XR, Jin H, et al. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies[J]. Eur J Pharm Biopharm, 2021, 163: 60-71. DOI:10.1016/j.ejpb.2021.03.008 [21] Moyer A, Tanaka K, Cheng EH. Apoptosis in cancer biology and therapy[J]. Annu Rev Pathol, 2025, 20(1): 303-328. DOI:10.1146/annurev-pathmechdis-051222-115023 [22] Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids[J]. Free Radic Biol Med, 1996, 20(7): 933-956. DOI:10.1016/0891-5849(95)02227-9 [23] Kuwar OK, Kalia N. Anti-inflammatory and antioxidant effects of baicalein: targeting Nrf2, and NF-B in neurodegenerative disease[J]. Inflammopharmacology, 2025, 33(3): 1303-1310. DOI:10.1007/s10787-025-01698-x [24] Bock FJ, Tait SWG. Mitochondria as multifaceted regulators of cell death[J]. Nat Rev Mol Cell Biol, 2020, 21(2): 85-100. DOI:10.1038/s41580-019-0173-8 [25] Abate M, Festa A, Falco M, et al. Mitochondria as playmakers of apoptosis, autophagy and senescence[J]. Semin Cell Dev Biol, 2020, 98: 139-153. DOI:10.1016/j.semcdb.2019.05.022 [26] Chen QS, Zheng AC, Xu XL, et al. Nrf3-mediated mitochondrial superoxide promotes cardiomyocyte apoptosis and impairs cardiac functions by suppressing Pitx2[J]. Circulation, 2025, 151(14): 1024-1046. DOI:10.1161/CIRCULATIONAHA.124.070286 |
| [1] | TANG Na, HUANG Guanjiang, LIN Xiaoxue, LIN Yushan, LI Lingjuan, LU Biaoqing. A bibliometric and visualization analysis of traditional Chinese medicine for sudden sensorineural hearing loss based on CiteSpacee [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(4): 10-18. |
| [2] | GUO Heling, ZHOU En, PENG Zhengjia, LIANG Fenfeng, QIN Nian. Changes in the disease burden of hearing loss in China from 1990 to 2023 and attributable analysis of occupational noise exposure: Based on GBD 2023 data [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(4): 19-27. |
| [3] | WANG Min, LIU Hao, JIANG Luhan, TAN Liyue, LI Wen, FU Xiaolong. Packaging of AAV-ie-Tnfaip8l2 and its effect on improving auditory function in Tnfaip8l2-/- mice [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 7-15. |
| [4] | WANG Menghui, LI Ao, WEI Hao, JIANG Yue, WU Xingguang, LI Luxi, QIAN Xiaoyun. Multiple mechanisms and clinical warning signs of deafness caused by hepatitis B virus [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 110-114. |
| [5] | WANG Kaijian, WANG Wei, CHEN Xuesheng, FAN Chunsun, HE Yingying, HUANG Dongling, QIAN Cunhui, DING Shujun. Correlation between neutrophil-to-lymphocyte ratio with hearing loss and audiometric thresholds in adults: a cross-sectional study based on NHANES [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(2): 18-28. |
| [6] | ZHANG Xiaohan, ZHU Liya, XIAO Yu, FU Xiaolong. Investigating the mechanism of Gasdermin D in cisplatin-induced stria vascularis injury using adeno-associated virus AAV1 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(2): 29-34. |
| [7] | TAO Duoduo, SHI Bin, ZHAO Yunshu, LI Yonggang, LIU Jisheng. Preliminary study on neurotransmitter levels in the anterior cingulate cortex and their relationship with hearing levels in patients with age-related hearing loss [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 31-39. |
| [8] | SUN Chunxiao, WANG Wenqing, YUE Tian, LIU Jisheng. Efficacy analysis of concurrent chemoradiotherapy with high and low cumulative cisplatin doses in the treatment of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 31-41. |
| [9] | ZHENG Zehao, WEI Jiali, LIU Jiatao, ZHOU Yuqi, SUN Wenting, LI Yuxuan, BAI Peng. Evaluation of the efficacy and safety of site-specific acupuncture for the treatment of sudden hearing loss: a systematic review and network Meta-analysis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 114-127. |
| [10] | LI Jie, SU Weina, LIN Qian, ZHANG Qishu, HOU Cheng, YANG Zhenjiao, XIANG Lili. Genetic analysis of MARVELD2 gene variants in two deafness cases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 128-134. |
| [11] | CHEN Ming, KE Bingbing, CUI Yaqi, WU Cuiping, CHEN Zhengnong, LI Chunyan, YIN Shankai. The antagonistic effects of NAD+ on cisplatin-induced oxidative stress injury in hair cells and the regulation of related gene expression [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 11-18. |
| [12] | DONG Lingkang, YU Dongzhen. Trends and projections of the burden of age-related hearing loss in China from 1990 to 2021 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 61-69. |
| [13] | ZHANG Lixia, LI Lin. Research on screening the key genes of age-related hearing loss by GEO database [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 104-114. |
| [14] | LIN Yushan, LU Biaoqing. Personalized use of batroxobin in the treatment of sudden sensorineural hearing loss with full frequency decline [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 115-121. |
| [15] | WANG Xin, YUAN Jingjing, HAO Pengpeng, YAN Zhanfeng, LIU Jianhua, ZHONG Liqun, LIU Siming, WU Wei, ZHAO Xiaoyang, ZHANG Ying. Protective effect of Chinese herbal medicine on sudden sensorineural hearing loss: a retrospective analysis and network pharmacology [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 6-17. |
|